To Evaluate the Frequency of Diabetes Mellitus Patients with Hepatitis C at Tertiary Hospital of Sindh, Pakistan
Journal of Pharmaceutical Research International,
Objective: The major theme of the research was to evaluate the frequency of diabetes mellitus patients with hepatitis C infection at tertiary care hospital of Sindh, Pakistan.
Methodology: Descriptive cross sectional study was conducted at tertiary care hospital of Sindh, Pakistan for the period of 08 months; total 374 sample size was calculated by using Rao soft sample size calculator at the prevalence rate of 58.3% and confidence level 95% and margin of error 5%. Data was collected from patients of sero-positive HCV-RNA (Hepatitis C Virus-Ribose Nucleic Acid) visiting outpatient department or admitted at tertiary care hospital of Sindh, Pakistan and Informed consent form was also filled from all included subjects and data was analyzed by using SPSS software version 24.00.
Results: From the 374 patients 209 were males and 165 females and all participants were divided in to various age groups as 15 patients were in the age group of 20-25 years, 67 patients were in 26-30 years, 48 patients included in 31-35 years and 109 patients were included in to age group of 36-40 years. Only 12 patients were included in the age group of 50 years and above. Total 164 (43.85%) were diabetic and 229 (61.22%) were diagnosed with Hepatitis C RNA (Ribose Nucleic Acid) positive. Patients had various range of HbA1c as 93 patients had range between 6-7mmol/dl. 107(28.60%) included in 7-9mmol/dl, 145(38.77%) included in 9-11mmol/dl and only 29 patients were having HbA1c (Glycated Hemoglobin) level above 11mmol/dl.
Conclusion: It was concluded that there were increased number of diabetic patients with hepatitis C in worsening condition, so the proper programs should be conducted in order to reduce the complication of co-morbid disease.
- Chronic liver disease
- diabetes mellitus
- Hepatitis C
How to Cite
Ali K, Memon S, Badar A, Zarrar M, Muhammad Y, Shaikh NS. Diabetes mellitus in Hepatitis C patients presenting to tertiary care facility, Nawabshah. Annals of Punjab Medical College (APMC). 2020; 14(1):58-61.
Yousaf MK, Nourin S, Khan A, Yousaf MI, Ullah SA, Lodhi S. Diabetes Mellitus Among Patients with Cirrhosis Due to Hepatitis C Virus and its Association with Hepatic Encephalopathy. Annals of King Edward Medical University. 2020;26(1):36-40.
Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, et al. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91(10): 1092-9.
Saddique M, Laique T. Frequency with risk factors for glucose intolerance in Hepatitis C patients; 2019.
Yuksel M, Akturk H, Arikan C. Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection. European Journal of Gastroenterology & Hepatology. 2020;32 (9):1251-5.
Wasuwanich P, Ingviya T, Thawillarp S, Teshale EH, Kamili S, Crino JP, et al. Hepatitis e‐associated hospitalizations in the United States: 2010‐2015 and 2015‐2017. Journal of viral hepatitis; 2020.
Kadla SA, Shah NA, Pathania R, Khan BA, Mir SA, Shah AI, Sheikh SA. Prevalence of diabetes mellitus in newly detected patients with hepatitis C. Journal of Diabetology. 2020;11(2):101.
Jabeen R, Mobin A, Mehmood K, Ali ST. Frequency of pre-diabetes, diabetes mellitus in non-alcoholic fatty liver disease. The Professional Medical Journal. 2020; 27(08):1703-9.
Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y. Diabetes and hepatitis C: A two-way association. Frontiers in Endocrinology. 2015;6:134.
Ueyama M, Nishida N, Korenaga M, Korenaga K, Kumagai E, Yanai H, et al. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. Journal of gastroenterology. 2016;51(4):370-9.
Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World journal of gastroenterology: WJG. 2012;18(14): 1642.
Memon MS, Arain ZI, Naz F, Zaki M, Kumar S, Burney AA. Prevalence of type 2 diabetes mellitus in Hepatitis C virus infected population: a Southeast Asian study. Journal of diabetes research; 2013.
Singh KK, Panda SK, Acharya SK. Patients with diabetes mellitus are prone to develop severe hepatitis and liver failure due to hepatitis virus infection. Journal of Clinical and Experimental hepatology. 2013;3(4):275-80.
Mansoor S, Bhutta S. Prevalence of diabetes in patients with HCV hepatitis and cirrhosis. Annals of Pakistan Institute of Medical Sciences. 2013;9(4):172-5.
Fabrizi F, Dixit V, Messa P. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology. 2019;43 (3):244-54.
Ferreira VS, Pernambuco RB, Lopes EP, Morais CN, Rodrigues MC, Arruda MJ, Vilar L. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arquivos Brasileiros de Endocrinologia & Metabologia. 2010;54 (4):362-8.
Atif M, Arshad S, Javaid K, ul Hassan M, Ahmad F, Imran M, et al. Diabetes and Hepatitis C: Two sides of a coin. Advancements in Life Sciences. 2017; 4(3):72-6.
Ghouri A, Kumar S, Khan SA, Ghani MH, Aslam S. Frequency of type 2 diabetes mellitus in patients with chronic hepatitis C virus infection. JLUMHS. 2014;13(02):51.
Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS, HALT-C Trial Group. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. The American Journal of Gastroenterology. 2012;107 (1):64.
Abstract View: 0 times
PDF Download: 0 times